OncLive | Bringing the Global Oncology Community Together

The FDA has approved the PI3K inhibitor alpelisib (Piqray) for the treatment of postmenopausal women, and men, with HR-positive, HER2-negative, PIK3CA-mutated, advanced or metastatic breast cancer following progression... Read More >>

FDA Approves Ruxolitinib for Steroid-Refractory Acute GVHD

TAS-102 Expands Arsenal in Gastric Cancer, But Long Road Ahead for Research

FDA Grants LN-145 Breakthrough Designation for Cervical Cancer

Investigators Hope Glioma Trial of Eflornithine Will Clinch Approval

Search Continues for Optimal HIPEC Use in Ovarian Cancer

View More Stories >>

View Conference Coverage

2019 ASCO Annual Meeting

2019 State of the Science Summit on Genitourinary Cancers in Needham

2019 State of the Science Summit on Hematologic Malignancies in Wisconsin

2019 European Lung Cancer Congress

2019 NCCN Annual Conference

Dr. Wang Discusses the Future of Treatment in MCL

Dr. Sabbatini on Frontline Treatment of Newly Diagnosed Ovarian Cancer

Dr. Barrientos on Remaining Challenges in CLL

Dr. McGregor on the Future of Cabozantinib in RCC

Dr. Powles on PD-L1 as a Biomarker in RCC

Dr. Mortimer on Brain Metastases in HER2+ Breast Cancer

Dr. Backes on the Utility of Sentinel Lymph Node Mapping in Cervical Cancer

OncLive houses thousands of videos that provide updates and information.
See more Videos

PARP + Maintenance Bevacizumab in Ovarian Cancer

Detecting Somatic BRCA1/2 Mutations in Ovarian Cancer

Genomic Testing: Sarcoma, Lung Cancer and Thyroid Cancer

SOLO-1 and PARP Inhibitors in Ovarian Cancer

Current Role of VEGF-Targeted Therapy in Ovarian Cancer

OncLive houses thousands of videos that provide updates and information.
See more Videos

The Changing Landscape in Molecular Testing

PD-L1 Testing in Stage III NSCLC & General Education

Assay Validation and Interdisciplinary Communication

How the Treatment of Stage III NSCLC Has Changed

Recommended Settings for Durvalumab Treatment

BRAF-Targeted Therapy in Melanoma: Toxicity Management

Recommendations for Managing BRAF+ Metastatic Melanoma

OncLive houses thousands of videos that provide updates and information.
See more Videos

Featured

Expert Anticipates Cure in Acute Lymphoblastic Leukemia

Elias Jabbour, MD, discussed recent clinical trial results in acute lymphoblastic leukemia, the role of immunotherapy, and the biggest challenges facing the field.

View more >>>